SUNILDAT D MAHESHWARI
Allopathic & Osteopathic Physicians|Family Medicine GILBERT, AZ NPI 1417153164
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine AZ Eli Lilly and Company All categories
General Payments — all program years on this page
$10,074.48
- Category: General Payments
- Program years: PY2018–2024
- Record count: 524
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,087.32 across 100 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,678.10 | 98 |
| Travel and Lodging | $409.22 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Eli Lilly and Company | $409.22 | 2 |
| ABBVIE INC. | $339.90 | 18 |
| Acerta Pharma LLC | $212.98 | 12 |
| Novo Nordisk AS | $171.31 | 13 |
| Lilly USA, LLC | $144.05 | 13 |
| DEXCOM, INC. | $82.57 | 4 |
| Mylan Specialty L.P. | $76.28 | 4 |
| PFIZER INC. | $73.47 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $65.41 | 3 |
| GlaxoSmithKline, LLC. | $50.64 | 3 |
| Corcept Therapeutics | $47.62 | 3 |
| Phathom Pharmaceuticals, Inc. | $45.63 | 2 |
| EISAI INC. | $44.02 | 2 |
| Merck Sharp & Dohme Corporation | $42.33 | 2 |
| INTRA-SANA LABORATORIES | $42.32 | 2 |
| Astellas Pharma US Inc | $37.00 | 2 |
| Medtronic, Inc. | $33.39 | 2 |
| SANOFI-AVENTIS U.S. LLC | $30.80 | 2 |
| Amgen Inc. | $30.59 | 2 |
| BIOTRONIK NRO, Inc. | $27.84 | 1 |
| Sumitomo Pharma America, Inc. | $26.30 | 1 |
| Gilead Sciences, Inc. | $23.53 | 1 |
| SCILEX PHARMACEUTICALS INC. | $15.51 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.61 | 1 |
By program year
Records — PY2024 (100)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.